期刊文献+

探讨中晚期宫颈癌患者同步放化疗与单纯放射治疗的临床疗效及不良反应 被引量:4

To Explore the Clinical Effects and Adverse Reactions of Concurrent Radiotherapy and Chemotherapy and Radiation Therapy Alone in Patients with Advanced Cervical Cancer
下载PDF
导出
摘要 目的探讨中晚期宫颈癌患者同步放化疗与单纯放射治疗的临床疗效及不良反应。方法纳入2009年1月至2017年1月这个时间段中入住我院的中晚期宫颈癌患者总计56例,按照患者的入院顺序给予前28例患者单纯放射疗法并划分为对照组,剩余28例入院时间较晚的患者则接受同步放化疗,将其划分为观察组,记录两种治疗方法下患者的病情改善情况以及出现不良反应的情况,综合分析不同治疗方法的应用效果。结果①观察组中疗效评定结果为显效以及有效的患者明显多于对照组(P<0.05)。②治疗结束后对患者随访至今,观察组患者1年内、2年内的生存质量均明显高于对照组(P<0.05)。③观察组内出现不良病症的患者明显多于对照组(P<0.05),但不良病症均处于患者耐受范围内。结论中晚期宫颈癌患者的治疗中选用同步放化疗能够有效改善患者的病情,延长患者的生存时间,所引发的不良反应均处于患者耐受范围内,综合应用价值与单纯放射疗法进行比较具有明显优势,值得推荐使用。 Objective To investigate the clinical effi cacy and adverse reactions of concurrent radiotherapy and chemotherapy alone in patients with advanced cervical cancer.Methods A total of 56 patients with advanced cervical cancer admitted to our hospital from January 2009 to January 2017 were enrolled.The fi rst 28 patients were treated with radiotherapy alone and divided into control group according to the order of admission.The remaining 28 patients were treated with concurrent radiotherapy and chemotherapy.The patients were divided into two groups.The improvement of patients'condition and the adverse reactions were recorded under the two treatment methods.The effects of different treatment methods were analyzed synthetically.Results(1)In the observation group,the effective and effective patients were signifi cantly more than those in the control group(P<0.05).(2)The patients in the observation group were followed up until now,and the patients in the observation group were within one year.The quality of life(QOL)in two years was signifi cantly higher than that in control group(P<0.05).(3)The number of patients with adverse disease in the observation group was signifi cantly higher than that in the control group(P<0.05),but the adverse symptoms were within the range of patient tolerance.Conclusion simultaneous radiotherapy and chemotherapy in the treatment of advanced cervical cancer can effectively improve the patient's condition,prolong the patient's survival time,and cause adverse reactions within the range of patient tolerance.Application value compared with radiotherapy alone has obvious advantages and is worthy of recommendation.
作者 董南 DONG Nan(Yingkou Central Hospital,Yingkou 115000,China)
机构地区 营口市中心医院
出处 《中国医药指南》 2020年第11期84-85,共2页 Guide of China Medicine
关键词 中晚期宫颈癌 同步放化疗 单纯放射疗法 临床疗效 不良反应 Advanced cervical cancer Concurrent radiotherapy and chemotherapy Radiotherapy alone Clinical effi cacy Adverse reactions
  • 相关文献

参考文献11

二级参考文献88

  • 1袁建军 ,何国照 .Ⅲ期宫颈癌的介入化疗16例临床分析[J].江苏大学学报(医学版),2004,14(4):363-363. 被引量:2
  • 2浦红,董若凡.宫颈癌的介入化疗进展[J].肿瘤学杂志,2007,13(2):113-116. 被引量:10
  • 3谷铣之.现代肿瘤学[M].北京:北京医科大学中国协和医科大学联合出版社,1995.486.
  • 4蔡茂怀,高红玉,熊军,柏会明,仇红艳,张景慧,严晓梅.HIFU结合全身化疗治疗宫颈癌放疗后残留17例近期疗效观察[J].上海医学影像,2007,16(4):303-304. 被引量:4
  • 5Kidd EA, Siegel BA, Dehdashti F, et al. Clinical outcomes of defini- tive intensity - modulated radiation therapy with fluorodeoxyglucose - positron emission tomography simulation in patients with locally ad- vanced cervical cancer [ J]. Int J Radiat Oncol Biol Phys, 2010, 77 (4) :1085 -1091.
  • 6Peters W A 3rd, Liu P Y,Barrett R J 2nd,et al. Concurrentchemotherapy and pelvic radiation therapy compared with pel-vic radiation therapy alone as adjuvant therapy after radicalsurgery in high-risk early-stage cancer of the cervix [ J ]. JClin Oncol, 2000,18(8) : 1606-1613.
  • 7Green J A,Kirwan J M,Tierney J F,ei al. Survival and re-currence after concomitant chemotherapy and radiotherapy forcancer of the uterine cervix ; a systematic review and meta-a-nalysis[J]. Lancet, 2001, 358(9284) : 781 -786. DOI:10.1016/S0140-6736( 01 )05965-7.
  • 8Bazan J G, Luxton G, Mok E C, ei al. Normal tissue compli-cation probability modeling of acute hematologic toxicity in pa-squamous cell carcinoma of the anal canal [ J ]. Int J RadiatOncol Biol Phys, 2012,84(3) : 700 -706. DOI: 10. 1016/j. ijrobp. 2011. 12.072.
  • 9Mauch P, Constine L, Greenberger J, et al. Hematopoieticstem cell compartment : acute and late effects of radiationtherapy and chemotherapy[ J]. Int J Radiat Oncol Biol Phys,1995, 31(5) : 1319 -1339. DOI: 10. 1016/0360-3016(94)00430-S.
  • 10Mell L K, Kochanski J D, Roeske J Cy et al. Dosimetric pre-dictors of acute hematologic toxicity in cervical cancer patientstreated with concurrent cisplatin and intensity-modulated pel-vic radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2006,66(5): 1356 -1365. DOI: 10. 1016/j. ijrobp. 2006. 03. 018.

共引文献220

同被引文献85

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部